Company Filing History:
Years Active: 2000
Title: Zhaohui Ao: Innovator in Immune Cell Apoptosis
Introduction
Zhaohui Ao is a notable inventor based in Devon, Pennsylvania. He has made significant contributions to the field of immunology, particularly in understanding the mechanisms of immune cell apoptosis. His work has implications for therapeutic strategies in cancer treatment and other immune-related disorders.
Latest Patents
Zhaohui Ao holds a patent for his invention titled "Siva genes, novel genes involved in CD27-mediated apoptosis." This patent encompasses isolated nucleic acid molecules known as Siva nucleic acid molecules, which encode proteins that play a crucial role in immune cell apoptosis. The invention also includes antisense nucleic acid molecules, recombinant expression vectors containing Siva nucleic acid molecules, and host cells that have been modified to express these vectors. Additionally, it covers nonhuman transgenic animals with introduced or disrupted Siva genes. The patent further provides isolated Siva proteins, fusion proteins, antigenic peptides, and anti-Siva antibodies, along with diagnostic, screening, and therapeutic methods utilizing these compositions.
Career Highlights
Zhaohui Ao is affiliated with the Dana-Farber Cancer Institute Inc., where he continues to advance research in cancer biology and immunology. His work has been instrumental in exploring the pathways that regulate immune responses, particularly in the context of cancer.
Collaborations
Zhaohui Ao has collaborated with esteemed colleagues such as Prasad V Kanteti and Stuart F Schlossman. These collaborations have fostered a rich environment for innovative research and development in the field of cancer immunology.
Conclusion
Zhaohui Ao's contributions to the understanding of immune cell apoptosis through his patented inventions highlight his role as a key innovator in the field. His work not only advances scientific knowledge but also paves the way for potential therapeutic applications in cancer treatment.